| 國家衛生研究院 |
2024-03-08 |
Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies
|
Wu, TY;Tsai, WT;Chen, KH;Huang, ST;Huang, CF;Kuo, PH;Tsai, MJ;Liu, WD;Lin, KY;Huang, YS;Cheng, A;Chen, PY;Sun, HY;Huang, HH;Huang, TC;Wu, SJ;Yao, M;Wang, JT;Sheng, WH;Hung, CC;Chen, YC;Chang, SC |
| 國家衛生研究院 |
2023-11 |
Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death
|
Lin, CP;Wu, SH;Lin, TY;Chu, CH;Lo, LW;Kuo, CC;Chang, JY;Hsu, SC;Ko, BS;Yao, M;Hsiao, JK;Wang, SW;Huang, DM |
| 臺大學術典藏 |
2022-09-07T06:39:29Z |
Simultaneous determination of triazole antifungal drugs in human plasma by sweeping-micellar electrokinetic chromatography
|
Lin S.-C.; Liu H.-Y.; SHU-WEN LIN; Yao M.; Wu U.-I.; Kuo H.-P.; Kuo C.-H. |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; SUNG-HSIN KUO; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-08-19T00:21:09Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Huang T.-C.; Ko B.-S.; Tang J.-L.; CHIUN HSU; Chen C.-Y.; Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2022-08-19T00:20:50Z |
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
|
Cheng A.-L.; Chen P.-J.; Liu T.-W.; Chang C.-S.; Tien H.-F.; CHIUN HSU; Tsou H.-H.; Lin S.-J.; Wang M.-C.; Yao M.; Hwang W.-L.; Kao W.-Y.; Chiu C.-F.; Lin S.-F.; Lin J. |
| 臺大學術典藏 |
2022-08-19T00:20:39Z |
Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection
|
CHIUN HSU; Taiwan Cooperative Oncology Group; Liu T.-W.; Chen P.-J.; Cheng A.-L.; Lin J.; Yuan Q.; Xia N.; Yao M.; Lin S.-J.; Chen J.-H.; Chang C.-S.; Pei S.-N.; Tsou H.-H.; Yang H.-C. |
| 臺大學術典藏 |
2022-06-27T07:07:38Z |
Soluble triggering receptor expressed on myeloid cells-1 as an infection marker for patients with neutropenic fever
|
Lin C.-H.; Yao M.; Hsu S.-C.; Ho C.-C.; Lin M.-T.; Lin C.-A.; Hu F.-C.; CHONG-JEN YU; Tien H.-F. |
| 臺大學術典藏 |
2022-06-27T07:06:26Z |
A patient with bronchiectasis presented with progressive dyspnoea and an unresolved right lower lung infiltrate
|
Lin P.-Y.; CHONG-JEN YU; Yao M.; Ku S.-C.; Lee L.-N.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:06:24Z |
Lung abscess due to Clostridium baratii infection in a patient with invasive pulmonary aspergillosis
|
Shu C.-C.; Yao M.; Hung C.-C.; Ku S.-C.; CHONG-JEN YU; Chang Y.-L. |
| 臺大學術典藏 |
2022-05-13T08:05:21Z |
Prior invasive fungal infection is not a contraindication for subsequent allogeneic bone marrow transplantation in adult patients with hematologic malignancies [4]
|
JANN-TAY WANG; Yao M.; Tang J.-L.; Chang S.-C.; Hung C.-C. |
| 臺大學術典藏 |
2022-05-11T07:47:53Z |
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
|
Hou H.-A.; Yao M.; Tang J.-L.|YIN-KAI CHEN; Ko B.-S.; Huang S.-Y.; Tien H.-F.; Chang H.-H.; Lu M.-Y.; Lin T.-T.; Lin K.-H.; Hsiao C.-H.; Lin C.-W.; Chen Y.-C. |
| 臺大學術典藏 |
2022-05-11T07:47:52Z |
The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression
|
Kuo Y.-Y.; Hou H.-A.|YIN-KAI CHEN; Li L.-Y.; Chen P.-H.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Chou W.-C.; Liu C.-Y.; Tang J.-L.; Yao M.; Tien H.-F. |
| 臺大學術典藏 |
2022-05-11T07:47:51Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
YIN-KAI CHEN; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-05-11T07:47:50Z |
Bisphenol A-induced DNA damages promote to lymphoma progression in human lymphoblastoid cells through aberrant CTNNB1 signaling pathway
|
YIN-KAI CHEN; Tan Y.-Y.; Yao M.; Lin H.-C.; Tsai M.-H.; Li Y.-Y.; Hsu Y.-J.; Huang T.-T.; Chang C.-W.; Cheng C.-M.; Chuang C.-Y. |
| 臺大學術典藏 |
2022-05-09T08:46:44Z |
Long-term outcome of allogeneic human leukocyte antigen-matched sibling-donor peripheral blood stem cell transplantation in leukaemia patients
|
Tang J.L.; Yao M.; Lu M.Y.; Ko B.S.; Lin D.T.; Lin K.H.; YEN-CHING CHEN |
| 臺大學術典藏 |
2022-04-26T07:24:38Z |
A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein�VBarr Virus
|
Yu S.-C.; KUAN-YIN KO; Teng S.-C.; Huang T.-C.; Lo H.-T.; Cheng C.-L.; Yao M.; Hong R.-L.; Chen C.-N.; Chen T.-C.; Yang T.-L. |
| 臺大學術典藏 |
2022-04-25T07:36:17Z |
Intracranial hemorrhage in adult patients with hematological malignancies
|
Chen C.-Y.; Tai C.-H.; Cheng A.; Wu H.-C.; Tsay W.; JIA-HAU LIU; Chen P.-Y.; Huang S.-Y.; Yao M.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T07:36:16Z |
Reduced incidence of interstitial pneumonitis after Allogeneic hematopoietic stem cell transplantation using a modified technique of total body irradiation
|
Chiang Y.; Tsai C.-H.; Kuo S.-H.; Liu C.-Y.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Lin C.-T.; Hou H.-A.; Chou W.-C.; JIA-HAU LIU; Lin C.-C.; Wu S.-J.; Hsu S.-C.; Chen Y.-C.; Lin K.-H.; Lin D.-T.; Chou H.-T.; Lu M.-Y.; Yang Y.-L.; Chang H.-H.; Liu M.-C.; Liao X.-W.; Wu J.-K.; Chou S.-C.; Cheng C.-L.; Chen C.-Y.; Tsay W.; Tien H.-F.; Tang J.-L.; Chen Y.-H. |
| 臺大學術典藏 |
2022-04-25T07:36:16Z |
Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia
|
Chen C.-Y.; Cheng A.; Huang S.-Y.; Sheng W.-H.; JIA-HAU LIU; Ko B.-S.; Yao M.; Chou W.-C.; Lin H.-C.; Chen Y.-C.; Tsay W.; Tang J.-L.; Chang S.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T07:36:15Z |
Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase
|
Yu S.-C.; Huang H.-H.; Li C.-C.; Tang J.-L.; Lee Y.-H.; Mao T.-L.; Kuo K.-T.; Lin C.-T.; JIA-HAU LIU; Ko B.-S.; Yao M. |
| 臺大學術典藏 |
2022-04-25T07:36:15Z |
Retrospective analysis of frontline treatment efficacy in elderly patients with diffuse large B-cell lymphoma
|
Cheng C.-L.; JIA-HAU LIU; Chou S.-C.; Yao M.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T07:36:14Z |
Pembrolizumab induced acute corneal toxicity after allogeneic stem cell transplantation
|
Hsiao C.-C.; Yao M.; JIA-HAU LIU; Chen W.-L. |
| 臺大學術典藏 |
2022-04-25T07:36:14Z |
Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome
|
Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; Hsu S.-C.; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; JIA-HAU LIU; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; Tang J.-L. |
| 臺大學術典藏 |
2022-04-25T07:36:14Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; JIA-HAU LIU; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T07:36:13Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
JIA-HAU LIU; Liao X.-W.; Chen C.-H.; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
| 臺大學術典藏 |
2022-04-25T07:36:12Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
Tien F.-M.; Tsai C.-H.; Huang S.-C.; JIA-HAU LIU; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; Hou H.-A.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-25T07:36:11Z |
Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
|
Wang Y.-H.; Tien F.-M.; Tsai C.-H.; Huang H.-H.; JIA-HAU LIU; Liao X.-W.; Tang J.-L.; Yao M.; Ko B.-S. |
| 臺大學術典藏 |
2022-04-25T07:36:11Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; Tien F.-M.; JIA-HAU LIU; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-04-25T06:13:23Z |
Bisphenol A-induced DNA damages promote to lymphoma progression in human lymphoblastoid cells through aberrant CTNNB1 signaling pathway
|
Chen Y.-K;Tan Y.-Y;Yao M;Lin H.-C;Tsai M.-H;Li Y.-Y;Hsu Y.-J;Huang T.-T;Chang C.-W;Cheng C.-M;Chuang C.-Y.; Chen Y.-K; Tan Y.-Y; Yao M; Lin H.-C; Tsai M.-H; Li Y.-Y; Hsu Y.-J; Huang T.-T; Chang C.-W; Cheng C.-M; Chuang C.-Y.; MONG-HSUN TSAI |
| 臺大學術典藏 |
2022-04-25T03:57:25Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H;Tang J.-L;Tien F.-M;Kuo Y.-Y;Wu D.-C;Lin C.-C;Tseng M.-H;Peng Y.-L;Hou M.-F;Chuang Y.-K;Liu M.-C;Liu C.-W;Yao M;Lin L.-I;Chou W.-C;Chen C.-Y;Hou H.-A;Tien H.-F.; Tsai C.-H; Tang J.-L; Tien F.-M; Kuo Y.-Y; Wu D.-C; Lin C.-C; Tseng M.-H; Peng Y.-L; Hou M.-F; Chuang Y.-K; Liu M.-C; Liu C.-W; Yao M; Lin L.-I; Chou W.-C; Chen C.-Y; Hou H.-A; Tien H.-F.; CHIEN-YU CHEN |
| 臺大學術典藏 |
2022-04-15T03:14:17Z |
Clinical and functional characterization of a novel STUB1 frameshift mutation in autosomal dominant spinocerebellar ataxia type 48 (SCA48)
|
Yu S.-C.; Ko K.-Y.; SHU-CHUN TENG; Huang T.-C.; Lo H.-T.; Cheng C.-L.; Yao M.; Hong R.-L.; Chen C.-N.; Chen T.-C.; Yang T.-L. |
| 臺大學術典藏 |
2022-04-14T07:20:28Z |
Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008�V2013
|
Chen C.-Y.; FENG-MING TIEN; Sheng W.-H.; Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2022-04-14T07:20:27Z |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
FENG-MING TIEN; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:27Z |
GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia
|
FENG-MING TIEN; Hou H.-A.; Tsai C.-H.; Tang J.-L.; Chiu Y.-C.; Chen C.-Y.; Kuo Y.-Y.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Lin C.-T.; Wu S.-J.; Ko B.-S.; Hsu S.-C.; Huang S.-Y.; Yao M.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:27Z |
Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan
|
Chen C.-Y.; FENG-MING TIEN; Cheng A.; Huang S.-Y.; Chou W.-C.; Yao M.; Tang J.-L.; Tien H.-F.; Sheng W.-H. |
| 臺大學術典藏 |
2022-04-14T07:20:26Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Tsai C.-H.; Yao C.-Y.; FENG-MING TIEN; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:26Z |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
FENG-MING TIEN; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:24Z |
Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax
|
Wang Y.-W.; Tsai C.-H.; Lin C.-C.; FENG-MING TIEN; Chen Y.-W.; Lin H.-Y.; Yao M.; Lin Y.-C.; Lin C.-T.; Cheng C.-L.; Tang J.-L.; Chou W.-C.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:23Z |
Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML
|
Tsai C.-H.; Tang J.-L.; FENG-MING TIEN; Kuo Y.-Y.; Wu D.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:23Z |
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
|
Wang Y.-H.; Lin C.-C.; Lee S.-H.; Tsai C.-H.; Wu S.-J.; Hou H.-A.; Huang T.-C.; Kuo Y.-Y.; Yao M.; Chang K.; Lin C.-W.; Lin Y.-C.; FENG-MING TIEN; Chou W.-C.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:22Z |
Polatuzumab vedotin�Vbased salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience
|
Wang Y.-W.; Tsai X.C.-H.; Hou H.-A.; FENG-MING TIEN; Liu J.-H.; Chou W.-C.; Ko B.-S.; Chen Y.-W.; Lin C.-C.; Cheng C.-L.; Lo M.-Y.; Lin Y.-C.; Lu L.-C.; Wu S.-J.; Kuo S.-H.; Hong R.-L.; Huang T.-C.; Yao M. |
| 臺大學術典藏 |
2022-04-14T07:20:22Z |
Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
|
FENG-MING TIEN; Tsai C.-H.; Huang S.-C.; Liu J.-H.; Chen C.-Y.; Kuo Y.-Y.; Chuang Y.-K.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Liao X.-W.; Lin L.-I.; Wu Y.-S.; Hou M.-F.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Chou W.-C.; Yao M.; Hou H.-A.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2022-04-14T07:20:21Z |
Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study
|
Wang Y.-H.; FENG-MING TIEN; Tsai C.-H.; Huang H.-H.; Liu J.-H.; Liao X.-W.; Tang J.-L.; Yao M.; Ko B.-S. |
| 臺大學術典藏 |
2022-04-08T09:23:13Z |
Requirement for LMP1-induced RON receptor tyrosine kinase in Epstein-Barr virus-mediated B-cell proliferation
|
Chou Y.-C.; Lin S.-J.; Lu J.; Yeh T.-H.; Chen C.-L.; Weng P.-L.; Lin J.-H.; Yao M.; CHING-HWA TSAI |
| 臺大學術典藏 |
2022-03-14T06:08:29Z |
Validation of a Post-Transplant Lymphoproliferative Disorder Risk Prediction Score and Derivation of a New Prediction Score Using a National Bone Marrow Transplant Registry Database
|
Lee C.-C.; Hsu T.-C.; Kuo C.-C.; Liu M.A.; Abdelfattah A.M.; Chang C.-N.; Yao M.; Li C.-C.; Wu K.-H.; Chen T.-C.; Gau J.-P.; Wang P.-N.; Liu Y.-C.; Chiou L.-W.; Lee M.-Y.; Li S.-S.; Chao T.-Y.; SHIANN-TANG JOU; Chang H.-H. |
| 臺大學術典藏 |
2022-02-23T02:12:31Z |
Development of immunity against hepatitis B virus after donor lymphocyte infusion in a peripheral blood stem cell transplantation recipient with chronic hepatitis B
|
Chiang L.-T.; Yao M.; Ko B.-S.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-23T02:12:23Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Liu J.-H.; Liao X.-W.; CHIEN-HUNG CHEN; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
| 臺大學術典藏 |
2022-02-22T05:34:23Z |
Development of immunity against hepatitis B virus after donor lymphocyte infusion in a peripheral blood stem cell transplantation recipient with chronic hepatitis B
|
Chiang L.-T.; Yao M.; Ko B.-S.; CHIEN-HUNG CHEN |
| 臺大學術典藏 |
2022-02-22T05:34:13Z |
Adoptive donor immunity protects against resolved hepatitis B virus reactivation after allogeneic haematopoietic stem cell transplantation in the world's largest retrospective cohort study
|
Liu J.-H.; Liao X.-W.; CHIEN-HUNG CHEN; Yao M.; Li C.-C.; Lin C.-T.; Tsai C.-H.; Chou W.-C.; Hou H.-A.; Huang S.-Y.; Wu S.-J.; Chen Y.-C.; Tien H.-F.; Tang J.-L.; Ko B.-S. |
